M.P.1.02 SNT-MC17/idebenone in the treatment of Friedreich’s ataxia: Preliminary safety data from a 12-month European randomized, placebo-controlled s

http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T9T-4WWHRS8-F&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&_docanchor=&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0027bdaeef768126216c15a42f58f113

M.P.1.02 SNT-MC17/idebenone in the treatment of Friedreich’s ataxia: Preliminary safety data from a 12-month European randomized, placebo-controlled study


J.B. Schulz1, T. Meier2 and G.L. Holder2
1University Medical Center, RWTH Aachen, Department of Neurology, Aachen, Germany
2Santhera Pharmaceuticals (Switzerland) Ltd., Liestal, Switzerland